Rchr
J-GLOBAL ID:201401016364268817   Update date: Aug. 23, 2024

Tamura Takao

タムラ タカオ | Tamura Takao
Affiliation and department:
Job title: Professor
Homepage URL  (1): http://kaken.nii.ac.jp/d/r/80324929.ja.html
Research field  (3): Gastroenterology ,  Tumor biology ,  Clinical pharmacy
Research keywords  (8): pancreatic cancer ,  Esophageal Cancer ,  Gastric cancer ,  フッ化ピリミジン系 ,  がん化学療法 ,  colorectal cancer ,  代謝拮抗剤 ,  適正使用
Research theme for competitive and other funds  (1):
  • 2008 - 2010 Appropriate use of the oral fluoropyrimidine anticancer drugs in patients with colorectal cancer
Papers (147):
  • Yu Sunakawa, Yasutoshi Kuboki, Jun Watanabe, Tetsuji Terazawa, Hisato Kawakami, Mitsuru Yokota, Masato Nakamura, Masahito Kotaka, Naotoshi Sugimoto, Hitoshi Ojima, et al. Exploratory Biomarker Analysis Using Plasma Angiogenesis-Related Factors and Cell-Free DNA in the TRUSTY Study: A Randomized, Phase II/III Study of Trifluridine/Tipiracil Plus Bevacizumab as Second-Line Treatment for Metastatic Colorectal Cancer. Targeted Oncology. 2024. 19. 1. 59-69
  • Masahiko Aoki, Shigenori Kadowaki, Naoki Takahashi, Takeshi Suzuki, Kotoe Oshima, Takayuki Ando, Yoshiyuki Yamamoto, Kentaro Kawakami, Yosuke Kito, Toshihiko Matsumoto, et al. Pattern of disease progression during third-line or later chemotherapy with nivolumab associated with poor prognosis in advanced gastric cancer: a multicenter retrospective study in Japan. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. 2022
  • Takahiko Ito, Atsuo Takashima, Kentaro Yamazaki, Hiroki Yukami, Hiroyuki Uetake, Masahiro Tsuda, Takeshi Suto, Toshikazu Moriwaki, Naotoshi Sugimoto, Hitoshi Ojima, et al. Primary tumor location as a predictor of survival in patients with RAS wild-type colorectal cancer who receive molecularly targeted drugs as first-line therapy: a multicenter real-world observational study by the Japanese Society for Cancer of the Colon and Rectum. International Journal of Clinical Oncology. 2022. 27. 9. 1450-1458
  • Yoon-Koo Kang, Satoshi Morita, Taroh Satoh, Min-Hee Ryu, Yee Chao, Ken Kato, Hyun Cheol Chung, Jen-Shi Chen, Kei Muro, Won Ki Kang, et al. Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 study. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. 2022. 25. 1. 207-217
  • Takahiro Kimura, Takayuki Takahama, Tomoko Wakasa, Shiori Adachi, Yusaku Akashi, Takao Tamura, Katsunari Yane. Role of debulking surgery in combination with immune therapy: A successfully treated case of locally advanced mucosal melanoma. Molecular and clinical oncology. 2022. 16. 1. 2-2
more...
MISC (161):
more...
Education (2):
  • 1991 - 1995 神戸大学大学院 医学研究科
  • 1982 - 1988 Kobe University School of Medicine
Professional career (1):
  • 博士(医学) (神戸大学大学院)
Work history (4):
  • 2017/04 - 現在 Kindai University
  • 2012/04 - 2017/03 Kindai University
  • 2008/06 - 2012/03 Kindai University Faculty of Medicine
  • 2005/01 - 2008/05 Kobe University
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page